Article Versions Notes

Lin D, Xu Y, Zhan H, Liang Y, Liu R, Liu J, Luo D, Chen X, Cai J, Zou Y. Targeting the ZMYM2-ANXA9 Axis with FLT3 Inhibitor G749 Overcomes Oxaliplatin Resistance in Colorectal Cancer. Biomedicines. 2025; 13(5):1247. https://doi.org/10.3390/biomedicines13051247

Lin, Dezheng, Yucheng Xu, Huanmiao Zhan, Yufan Liang, Riyun Liu, Jun Liu, Dandong Luo, Xiaochuan Chen, Jiawei Cai, and Yifeng Zou. 2025. "Targeting the ZMYM2-ANXA9 Axis with FLT3 Inhibitor G749 Overcomes Oxaliplatin Resistance in Colorectal Cancer" Biomedicines 13, no. 5: 1247. https://doi.org/10.3390/biomedicines13051247

Lin, D., Xu, Y., Zhan, H., Liang, Y., Liu, R., Liu, J., Luo, D., Chen, X., Cai, J., & Zou, Y. (2025). Targeting the ZMYM2-ANXA9 Axis with FLT3 Inhibitor G749 Overcomes Oxaliplatin Resistance in Colorectal Cancer. Biomedicines, 13(5), 1247. https://doi.org/10.3390/biomedicines13051247